IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 362 filers reported holding IONIS PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 0.54 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $1,298 | +3.6% | 29,965 | +20.9% | 0.01% | 0.0% |
| Q4 2023 | $1,253 | +28.6% | 24,779 | -3.9% | 0.01% | +25.0% |
| Q4 2022 | $974 | -99.9% | 25,791 | +49.0% | 0.00% | 0.0% |
| Q3 2022 | $765,000 | +1076.9% | 17,308 | +1090.4% | 0.00% | – |
| Q1 2021 | $65,000 | -20.7% | 1,454 | 0.0% | 0.00% | – |
| Q4 2020 | $82,000 | -58.4% | 1,454 | -52.6% | 0.00% | -100.0% |
| Q2 2019 | $197,000 | -3.0% | 3,068 | +22.6% | 0.00% | 0.0% |
| Q1 2019 | $203,000 | +93.3% | 2,502 | -3.8% | 0.00% | – |
| Q1 2016 | $105,000 | -30.5% | 2,602 | +6.6% | 0.00% | -100.0% |
| Q4 2015 | $151,000 | – | 2,441 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sicart Associates LLC | 367,360 | $14,768,000 | 10.67% |
| BB BIOTECH AG | 7,461,295 | $299,944,000 | 9.81% |
| TANAKA CAPITAL MANAGEMENT INC | 83,399 | $3,353,000 | 7.39% |
| DOWLING & YAHNKE LLC | 675,843 | $27,169,000 | 2.89% |
| Opus Point Partners Management, LLC | 78,900 | $3,172,000 | 2.35% |
| Motley Fool Asset Management LLC | 259,000 | $10,412,000 | 2.25% |
| ARK Investment Management | 127,563 | $5,128,000 | 1.48% |
| Motley Fool Wealth Management, LLC | 325,965 | $13,104,000 | 1.26% |
| PINNACLE ASSOCIATES LTD | 1,514,710 | $60,891,000 | 1.16% |
| Bellevue Group AG | 205,253 | $8,251,000 | 1.10% |